Search results
Results From The WOW.Com Content Network
Lipidomics is the large-scale study of pathways and networks of cellular lipids in biological systems. [ 1 ] [ 2 ] [ 3 ] The word " lipidome " is used to describe the complete lipid profile within a cell, tissue, organism, or ecosystem and is a subset of the " metabolome " which also includes other major classes of biological molecules (such as ...
LIPID MAPS was founded in 2003 with NIH funding. [14] LIPID MAPS was previously funded by a multi-institutional grant from Wellcome, and is now funded under an MRC Partnership award, held jointly by University of Cardiff led by Prof Valerie O'Donnell, the Babraham Institute, UCSD and Swansea University, and The University of Edinburgh.
Lipidomics is a research field that studies the pathways and networks of cellular lipids in biological systems (i.e., lipidomes) on a large scale. It involves the identification and quantification of the thousands of cellular lipid molecular species and their interactions with other lipids, proteins, and other moieties in vivo.
Diagram illustrating genomics. Omics is the collective characterization and quantification of entire sets of biological molecules and the investigation of how they translate into the structure, function, and dynamics of an organism or group of organisms.
The Journal of Cancer Research and Therapeutics is a peer-reviewed open access medical journal published by Medknow Publications on behalf of the Association of Radiation Oncologists of India. The journal covers research in oncology , radiation oncology , medical imaging , radiation protection , non-ionising radiation , and radiobiology .
Systems immunology is a research field under systems biology that uses mathematical approaches and computational methods to examine the interactions within cellular and molecular networks of the immune system. [1]
Leukemia Research is a monthly peer-reviewed medical journal covering research on hematologic malignancies. It was established in 1977 and is published by Elsevier . The editor-in-chief is Clive S. Zent ( James P. Wilmot Cancer Center ).
FLAG is a chemotherapy regimen used for relapsed and refractory acute myeloid leukemia (AML). [1] The acronym incorporates the three primary ingredients of the regimen: . Fludarabine: an antimetabolite that, while not active toward AML, increases formation of an active cytarabine metabolite, ara-CTP, in AML cells;